AAAAAA
Results:
1-15
|
Results: 15
Authors:
Tas, F
Basaran, M
Aydiner, A
Eralp, Y
Topuz, E
Citation: F. Tas et al., 5-fluorouracil-induced balanitis in a patient with oesophageal carcinoma, CL ONCOL-UK, 13(3), 2001, pp. 170-171
Authors:
Tas, F
Aydiner, A
Tenekeci, N
Karadeniz, A
Sakar, B
Topuz, E
Citation: F. Tas et al., Hypertrophic osteoarthropathy associated with docetaxel treatment, CL ONCOL-UK, 13(2), 2001, pp. 145-146
Authors:
Topuz, E
Eralp, Y
Saip, P
Aydiner, A
Tas, F
Salihoglu, Y
Berkman, S
Bengisu, E
Citation: E. Topuz et al., The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage IC ovarian carcinoma, EUR J GYN O, 22(1), 2001, pp. 70-73
Authors:
Eralp, Y
Aydiner, A
Tas, F
Saip, P
Topuz, E
Citation: Y. Eralp et al., Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation, AM J CL ONC, 24(4), 2001, pp. 347-350
Authors:
Tas, F
Aydiner, A
Demir, C
Topuz, E
Citation: F. Tas et al., Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer, AM J CL ONC, 24(4), 2001, pp. 376-378
Authors:
Tas, F
Aykan, F
Aydiner, A
Yasasever, V
Topuz, E
Citation: F. Tas et al., Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer, AM J CL ONC, 24(2), 2001, pp. 148-149
Authors:
Goksel, HM
Karadag, O
Turaclar, U
Tas, F
Oztoprak, I
Citation: Hm. Goksel et al., Nitric oxide synthase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental cerebral vasospasm model, ACT NEUROCH, 143(4), 2001, pp. 383-391
Authors:
Tas, F
Aydiner, A
Topuz, E
Yasasever, V
Karadeniz, A
Saip, P
Citation: F. Tas et al., Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer, J EXP CL C, 19(4), 2000, pp. 477-481
Authors:
Topuz, E
Aydiner, A
Saip, P
Eralp, Y
Tas, F
Salihoglu, Y
Tenekeci, N
Citation: E. Topuz et al., Correlations of serum CA125 level and computerized tomography (CT) imagingwith laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer, EUR J GYN O, 21(6), 2000, pp. 599-602
Authors:
Tas, F
Yavuz, E
Aydiner, A
Saip, P
Disci, R
Iplikci, A
Topuz, E
Citation: F. Tas et al., Angiogenesis and p53 protein expression in breast cancer - Prognostic roles and interrelationships, AM J CL ONC, 23(6), 2000, pp. 546-553
Authors:
Aydiner, A
Karadeniz, A
Uygun, K
Tas, S
Tas, F
Disci, R
Topuz, E
Citation: A. Aydiner et al., Multiple primary neoplasms at a single institution - Differences between synchronous and metachronous neoplasms, AM J CL ONC, 23(4), 2000, pp. 364-370
Authors:
Tas, F
Aykan, NF
Aydiner, A
Uygun, K
Basaran, M
Camlica, H
Topuz, E
Citation: F. Tas et al., The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival, AM J CL ONC, 23(1), 2000, pp. 53-57
Celsite (R) port and catheter as an intraperitoneal access device in the treatment of ovarian cancer
Authors:
Topuz, E
Salihoglu, Y
Aydiner, A
Saip, P
Tas, F
Sozen, T
Berkman, S
Bengisu, E
Citation: E. Topuz et al., Celsite (R) port and catheter as an intraperitoneal access device in the treatment of ovarian cancer, J SURG ONC, 74(3), 2000, pp. 223-226
Authors:
Tas, F
Aydiner, A
Topuz, E
Camlica, H
Saip, P
Eralp, Y
Citation: F. Tas et al., Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer, ACTA ONCOL, 38(8), 1999, pp. 1011-1015
Authors:
Icli, F
Celik, I
Aykan, F
Uner, A
Demirkazik, A
Ozet, A
Ozguroglu, M
Tas, F
Akbulut, H
Firat, D
Citation: F. Icli et al., A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma, CANCER, 83(12), 1998, pp. 2475-2480
Risultati:
1-15
|